(Q33816805)

29 July 2017

0 references

Rituximab for plasma exchange-dependent recurrent focal segmental glomerulosclerosis after renal transplantation (English)

1 reference

focal segmental glomerulosclerosis

29 July 2017

main subject

1 reference

1 reference

Jeroen K J Deegens

1

1 reference

29 July 2017

Jack F M Wetzels

series ordinal

2

1 reference

29 July 2017

publication date

14 January 2008

1 reference

29 July 2017

1 reference

29 July 2017

volume

1

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

85-88

1 reference

Creative Commons Attribution-NonCommercial 4.0 International

29 July 2017

copyright license

start time

3 October 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

B-cell-targeted therapy for systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5477908

Reconstitution of the adult B cell repertoire after treatment with rituximab

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5477908

Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5477908

The central and multiple roles of B cells in lupus pathogenesis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5477908

Pathogenesis of lipoid nephrosis: a disorder of T-cell function

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5477908

Rituximab and nephrotic syndrome: a new therapeutic hope?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5477908

Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5477908

Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5477908

Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5477908

Plasma cells for a lifetime?

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5477908

Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome

30 October 2018

1 reference

12 December 2020

Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplant

1 reference

12 December 2020

Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis

1 reference

12 December 2020

Bone marrow B-lineage cells in patients with rheumatoid arthritis following rituximab therapy

1 reference

12 December 2020

Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment

1 reference

12 December 2020

Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients

1 reference

12 December 2020

Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports

1 reference

12 December 2020

Post-transplant focal segmental glomerulosclerosis refractory to plasmapheresis and rituximab therapy

1 reference

12 December 2020

Does rituximab treat recurrent focal segmental glomerulosclerosis post-renal transplantation?

1 reference

12 December 2020

Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy

1 reference

12 December 2020

Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment

1 reference

12 December 2020

Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab

1 reference

12 December 2020

Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis

1 reference

12 December 2020

A glomerular permeability factor produced by human T cell hybridomas

1 reference

12 December 2020

Identifiers

DOI

10.1093/NDTPLUS/SFM048

1 reference

29 July 2017

1 reference

29 July 2017

1 reference